SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-223083
Filing Date
2017-07-06
Accepted
2017-07-06 16:51:58
Documents
8
Period of Report
2017-08-10
Effectiveness Date
2017-07-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A d271932ddef14a.htm DEF 14A 1169407
2 GRAPHIC g271932001.jpg GRAPHIC 33177
3 GRAPHIC g271932002.jpg GRAPHIC 9183
4 GRAPHIC g271932003.jpg GRAPHIC 3036
5 GRAPHIC g271932004.jpg GRAPHIC 14891
6 GRAPHIC g271932005.jpg GRAPHIC 3638
7 GRAPHIC g271932g12y68.jpg GRAPHIC 23045
8 GRAPHIC g271932g65t06.jpg GRAPHIC 27367
  Complete submission text file 0001193125-17-223083.txt   1329053
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
WAVE Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 17952673
SIC: 2834 Pharmaceutical Preparations